» Articles » PMID: 29757986

Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus

Abstract

Since the beginning of the epidemic, human immunodeficiency virus (HIV) has infected around 70 million people worldwide, most of whom reside is sub-Saharan Africa. There have been very promising developments in the treatment of HIV with anti-retroviral drug cocktails. However, drug resistance to anti-HIV drugs is emerging, and many people infected with HIV have adverse reactions or do not have ready access to currently available HIV chemotherapies. Thus, there is a need to discover new anti-HIV agents to supplement our current arsenal of anti-HIV drugs and to provide therapeutic options for populations with limited resources or access to currently efficacious chemotherapies. Plant-derived natural products continue to serve as a reservoir for the discovery of new medicines, including anti-HIV agents. This review presents a survey of plants that have shown anti-HIV activity, both in vitro and in vivo.

Citing Articles

Prospects of in the treatment of human viral infections: A comprehensive and a systematic review.

Masooma , Qaiser A, Ali D, Manzoor D Heliyon. 2024; 10(21):e39635.

PMID: 39553635 PMC: 11566848. DOI: 10.1016/j.heliyon.2024.e39635.


Green-synthesized silver nanoparticles from as a promising strategy to target quorum sensing and biofilms in .

Owrang M, Gholami A Heliyon. 2024; 10(19):e38395.

PMID: 39398045 PMC: 11467639. DOI: 10.1016/j.heliyon.2024.e38395.


Surface modification of graphene and fullerene with Sulfur (S), Selenium (Se), and Oxygen (O): DFT Simulation for enhanced zidovudine delivery in HIV treatment.

Akor F, Edo G, Nelson F, Johnson A, Iyam S, Abubakar M BMC Chem. 2024; 18(1):156.

PMID: 39192298 PMC: 11351320. DOI: 10.1186/s13065-024-01259-3.


Leading Paediatric Infectious Diseases-Current Trends, Gaps, and Future Prospects in Oral Pharmacotherapeutic Interventions.

Rampedi P, Ogunrombi M, Adeleke O Pharmaceutics. 2024; 16(6).

PMID: 38931836 PMC: 11206886. DOI: 10.3390/pharmaceutics16060712.


Impact of silver nanoparticles on secondary metabolite composition and toxicity in anise (Pimpinella anisum L.) callus culture.

Ulusoy E, Bozkurt A, Durmaz S, Servi H, Vardar F, Erisen S BMC Plant Biol. 2024; 24(1):362.

PMID: 38702604 PMC: 11069286. DOI: 10.1186/s12870-024-05067-8.


References
1.
Behbahani M . Evaluation of anti-HIV-1 activity of a new iridoid glycoside isolated from Avicenna marina, in vitro. Int Immunopharmacol. 2014; 23(1):262-6. DOI: 10.1016/j.intimp.2014.09.003. View

2.
Mujovo S, Hussein A, Meyer J, Fourie B, Muthivhi T, Lall N . Bioactive compounds from Lippia javanica and Hoslundia opposita. Nat Prod Res. 2008; 22(12):1047-54. DOI: 10.1080/14786410802250037. View

3.
ABDEL-MALEK S, Bastien J, Mahler W, Jia Q, Reinecke M, Robinson Jr W . Drug leads from the Kallawaya herbalists of Bolivia. 1. Background, rationale, protocol and anti-HIV activity. J Ethnopharmacol. 1996; 50(3):157-66. DOI: 10.1016/0378-8741(96)01380-3. View

4.
Olatunya O, Olatunya A, Anyabolu H, Adejuyigbe E, Oyelami O . Preliminary trial of aloe vera gruel on HIV infection. J Altern Complement Med. 2012; 18(9):850-3. DOI: 10.1089/acm.2010.0735. View

5.
Yu Z, Niu Z, Li X, Zheng C, Song X, Chen G . New phenylpropanoid and 6H-dibenzo[b,d]pyran-6-one derivatives from the stems of Dasymaschalon rostratum. Fitoterapia. 2017; 118:27-31. DOI: 10.1016/j.fitote.2017.02.003. View